在患有ST段升高心肌梗塞的患者中,直接支架与传统支架相比,心肌梗塞-A COMPARE CRUSH子研究
Rosanne F Vogel1,2, Ronak Delewi2, Jeroen M Wilschut3
1Department of Cardiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Journal of clinical medicine
|October 28, 2023
概括
直接支架 (DS) 和常规支架 (CS) 在ST段升高心肌梗塞 (STEMI) 患者中显示出类似的早期转血结果. 在这项研究中,这两种方法都证明了可比的支架直径和一年的血管通透性.
科学领域:
- 干预心脏病学 干预心脏病学
- 心血管研究研究心血管研究
- 医疗器械技术 医疗器械技术
背景情况:
- 直接支架 (DS) 可以减少皮肤通冠状动脉干预 (PCI) 期间的远端栓塞,可能改善组织再输液.
- 然而,与传统支架 (CS) 相比,DS可能会增加支架不充分扩张和损失失败的风险.
- 这项研究调查了ST段升高心肌梗塞 (STEMI) 患者的这些结果.
研究的目的:
- 为了比较直接支架 (DS) 与常规支架 (CS) 在接受初级PCI的STEMI患者的疗效.
- 评估支架直径,早期再输 (TIMI流量,ST段分辨率) 和长期目标病变失败的差异.
主要方法:
- 随机对比CRUSH试验的一项子研究,涉及446名当代预先治疗的STEMI患者.
- DS与CS的比较,评估支架直径,PCI后的TIMI流量,一小时的ST段分辨率 (STR) 和一年的目标损伤失败.
- 使用倾向性得分权重来调整比例变量中的潜在治疗选择偏差.
主要成果:
- 在DS和CS组之间,支架直径是可比的 (3.2±0.5毫米).
- 后PCI TIMI 3流量 (93%对90%) 和完整STR率 (72%对58%) 在DS和CS之间是相似的.
- 一年目标损伤失败率也是可比的 (2%的DS对比1%的CS).
结论:
- 在这个STEMI队列中,直接支架 (DS) 与常规支架 (CS) 相比,早期心肌再输的结果没有差异.
- DS证明了与CS相比的支架直径和一年的血管通透性.
- 研究结果表明,在预先治疗的STEMI患者中,DS是一种可行的CS替代品,具有类似的安全性和有效性.
相关概念视频
Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12


